Oura’s recent postponement of its planned September 2026 Nasdaq IPO, despite 3-4x book coverage and $400 million in cornerstone interest, is the dominant factor behind the 94.8% market-implied probability of no IPO before January 2027. The company cited IPO-market uncertainty after investors flagged the $13.5–15.6 billion target valuation as aggressive relative to its $11 billion Series E mark and the 73% secondary component. With strong revenue growth (projected 90% for fiscal 2026), recent profitability, and over 6 million paid members, Oura has the financial flexibility to wait. The absence of any new filing or pricing window since late September reinforces trader consensus. A clearer equity-market window or sustained risk appetite could still prompt a relaunch in the narrow remaining timeframe.